RxDoctor Payments Data

Stephanie Eldridge

Podiatrist · Hickory, NCNPI 1730529470

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,235 of the $3,805 with a category attached, or 85.0%. 34 manufacturers reported payments, led by Convatec Inc. at 32.2% of the total.

$3,805in general payments, 2019–2025

Across 110 payments — averaging $34.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Convatec Inc.$1K
  • Organogenesis Inc.$792
  • Smith+Nephew$260
  • Sanara Medtech Inc.$217
  • Musculoskeletal Transplant Foundation Inc.$193
  • Paratek Pharmaceuticals, Inc.$109
  • plus $1K from 28 others

What the payments were for

  • Travel & lodging$54614%
  • Food & beverage$3,23585%
  • Entertainment$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,805 in reported general payments places this provider in the 70th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$135,542
Medicare patients
557
Services billed
2,423

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip59$1,834
Ciclopirox43$1,451
Ammonium Lactate40$840
Mupirocin75$553
Ketoconazole21$501
Nitroglycerin PatchNitroglycerin15$368
Doxycycline Hyclate13$227
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav26$200
Gabapentin11$52
Meloxicam12$23

Paid to pharmacies, not to this prescriber.

Other podiatrist in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →